Tag: Covaxin

COVAXIN Creator Dr. Krishna Ella Wins Prestigious Johns Hopkins Award

May 24, 2024: Dr. Krishna Ella, Co-founder and Executive Chairman of Bharat Biotech, has been awarded the prestigious

Covaxin: Facts vs. Fiction – Separating Truth from Misinformation

May 18, 2024: Covaxin, an inactivated virus vaccine developed by Bharat Biotech in India, has played a significant

Covaxin BHU Study: BB Points Flaws in Data Points, Backs Strong Safety Track Record

May 16, 2024: A recent study in SpringerLink examining Covaxin's long-term effects offers debatable findings. While the research

COVAXIN Safety Assured: Bharat Biotech Puts Safety First

May 2, 2024: In the interest of public health, Bharat Biotech reaffirmed the safety of India's COVAXIN®️, developed

COVAXIN production to be demand-driven, says Bharat Biotech

Bharat Biotech, the Hyderabad-based vaccine maker of COVAXIN, announced that it will wait and assess the demand before

Bharat Biotech firmly condemns baseless reports on COVAXIN Development

Bharat Biotech today strongly condemned fallacious and misleading information report recently by a foreign media. The company in

Japan Approves COVAXIN booster dose for Travelers; reinforces the effectiveness of Universal Covid Vaccine

Japan on Friday accorded approval for Bharat Biotech's Covaxin booster dose for travellers. In April this year, the

COVAXIN booster can defend new variants of concern: ICMR Study

A COVAXIN booster dose has protective efficacy against the Delta variant and the Omicron sub-variants BA.1.1 and BA.2,

COVAXIN Commercialisation Rights In Mexico Given To Ocugen

Covaxin Commercialisation rights has been secured by Ocugen Inc. Ocugen and Bharat Biotech has entered into amended agreement

Japan to Welcome COVAXIN Jabbed Travelers from April 10, 2022

COVAXIN Jabbed who were worried to know if Japan will allow entry can now relax as Japan has

Science is Rewarding, if You Defeat the Odds – COVAXIN Scientist Krishna

Science pays, if you are passionate, and committed towards it, COVAXIN Scientist Krishna Ella said. Addressing young entrepreneurs

India’s COVAXIN, Long Awaited in the US to be Evaluated by FDA

COVAXIN maker Bharat Biotech announced today that U.S. Food and Drug Administration (FDA) has lifted its clinical hold